ATC code J06: Difference between revisions
Jump to navigation
Jump to search
imported>Whywhenwhohow |
imported>Whywhenwhohow anchors, 2026 updates |
||
| Line 1: | Line 1: | ||
{{ATC codes lead|J|06|Immune sera and immunoglobulins|vet=no}} | {{ATC codes lead|J|06|Immune sera and immunoglobulins|vet=no}} | ||
== | ==<span class="anchor" id="J06A"></span>J06A Immune sera== | ||
=== | ===<span class="anchor" id="J06AA"></span>J06AA Immune sera=== | ||
:J06AA01 [[Diphtheria antitoxin]] | :J06AA01 [[Diphtheria antitoxin]] | ||
:J06AA02 [[Tetanus antitoxin]] | :J06AA02 [[Tetanus antitoxin]] | ||
| Line 11: | Line 11: | ||
:J06AA06 [[Rabies serum]] | :J06AA06 [[Rabies serum]] | ||
== | ==<span class="anchor" id="J06B"></span>J06B Immunoglobulins== | ||
=== | ===<span class="anchor" id="J06BA"></span>J06BA Immunoglobulins, normal human=== | ||
:J06BA01 [[Immunoglobulin therapy|Immunoglobulins, normal human, for extravascular administration]] | :J06BA01 [[Immunoglobulin therapy|Immunoglobulins, normal human, for extravascular administration]] | ||
:J06BA02 [[Immunoglobulin therapy|Immunoglobulins, normal human, for intravascular administration]] | :J06BA02 [[Immunoglobulin therapy|Immunoglobulins, normal human, for intravascular administration]] | ||
=== | ===<span class="anchor" id="J06BB"></span>J06BB Specific immunoglobulins=== | ||
:J06BB01 [[Anti-D (rh) immunoglobulin]] | :J06BB01 [[Anti-D (rh) immunoglobulin]] | ||
:J06BB02 [[Anti-tetanus immunoglobulin|Tetanus immunoglobulin]] | :J06BB02 [[Anti-tetanus immunoglobulin|Tetanus immunoglobulin]] | ||
| Line 36: | Line 36: | ||
:J06BB30 Combinations | :J06BB30 Combinations | ||
=== | ===<span class="anchor" id="J06BC"></span>J06BC Antibacterial monoclonal antibodies=== | ||
:J06BC01 [[Nebacumab]] | :J06BC01 [[Nebacumab]] | ||
:J06BC02 [[Raxibacumab]] | :J06BC02 [[Raxibacumab]] | ||
| Line 42: | Line 42: | ||
:J06BC04 [[Obiltoxaximab]] | :J06BC04 [[Obiltoxaximab]] | ||
=== | ===<span class="anchor" id="J06BD"></span>J06BD Antiviral monoclonal antibodies=== | ||
:J06BD01 [[Palivizumab]] | :J06BD01 [[Palivizumab]] | ||
:J06BD02 [[Motavizumab]] | :J06BD02 [[Motavizumab]] | ||
| Line 52: | Line 52: | ||
:J06BD08 [[Nirsevimab]] | :J06BD08 [[Nirsevimab]] | ||
:J06BD09 [[Sipavibart]] | :J06BD09 [[Sipavibart]] | ||
:J06BD10 [[Clesrovimab]] | |||
:J06BD11 [[Libevitug]] | |||
==See also== | ==See also== | ||
Latest revision as of 00:38, 24 December 2025
J06A Immune sera
J06AA Immune sera
- J06AA01 Diphtheria antitoxin
- J06AA02 Tetanus antitoxin
- J06AA03 Snake venom antiserum
- J06AA04 Botulinum antitoxin
- J06AA05 Gas-gangrene sera
- J06AA06 Rabies serum
J06B Immunoglobulins
J06BA Immunoglobulins, normal human
- J06BA01 Immunoglobulins, normal human, for extravascular administration
- J06BA02 Immunoglobulins, normal human, for intravascular administration
J06BB Specific immunoglobulins
- J06BB01 Anti-D (rh) immunoglobulin
- J06BB02 Tetanus immunoglobulin
- J06BB03 Varicella/zoster immunoglobulin
- J06BB04 Hepatitis B immunoglobulin
- J06BB05 Rabies immunoglobulin
- J06BB06 Rubella immunoglobulin
- J06BB07 Vaccinia immunoglobulin
- J06BB08 Staphylococcus immunoglobulin
- J06BB09 Cytomegalovirus immunoglobulin
- J06BB10 Diphtheria immunoglobulin
- J06BB11 Hepatitis A immunoglobulin
- J06BB12 Encephalitis, tick-borne immunoglobulin
- J06BB13 Pertussis immunoglobulin
- J06BB14 Morbilli immunoglobulin
- J06BB15 Parotitis immunoglobulin
- J06BB19 Anthrax immunoglobulin
- J06BB30 Combinations
J06BC Antibacterial monoclonal antibodies
- J06BC01 Nebacumab
- J06BC02 Raxibacumab
- J06BC03 Bezlotoxumab
- J06BC04 Obiltoxaximab
J06BD Antiviral monoclonal antibodies
- J06BD01 Palivizumab
- J06BD02 Motavizumab
- J06BD03 Tixagevimab and cilgavimab
- J06BD04 Ansuvimab
- J06BD05 Sotrovimab
- J06BD06 Regdanvimab
- J06BD07 Casirivimab and imdevimab
- J06BD08 Nirsevimab
- J06BD09 Sipavibart
- J06BD10 Clesrovimab
- J06BD11 Libevitug
See also
References
<templatestyles src="Reflist/styles.css" />
Script error: No such module "Check for unknown parameters".